Stockholm – November 29, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, is pleased to announce that Arto Järvinen has been promoted to the company’s CTO position. Järvinen has been Director of R&D since 2011 and has been instrumental in leading the company’s operational R&D work. Järvinen has succeeded the former CTO and co-founder Martin Hedlund. Hedlund retired earlier this year but will resume in his board position for the company.
“We are very pleased that Arto Järvinen is the new CTO at ContextVision. The company is in a transformational period where artificial intelligence technology plays a key role, especially as we are in the process of expanding our business portfolio and entering into the digital pathology market. The CTO role is very important in this journey and I’m confident that Arto’s leadership, knowledge and experience will be extremely valuable for our company,” says ContextVision’s CEO Fredrik Palm.
“It has never been a more exciting time to be an engineer than now. Converging and exponential technologies make products only dreamt of ten years ago a reality today. My highest priority as the CTO of ContextVision is to make sure that ContextVision stays at the forefront of innovation by managing a portfolio of cutting-edge research projects,” says Järvinen.
“Martin Hedlund is one of the founders of ContextVision, he has spent his carrier building and developing the company. His entrepreneurial mindset combined with technical know-how and experience has been instrumental in making ContextVision a leader in image enhancement and analysis. In addition, he has played a key role in the adoption of AI-technology within the company to prepare for further growth. We truly want to thank Martin for all these years,” says Palm.
For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 76 870 25 43 or visit www.contextvision.com.
About ContextVision
ContextVision is a medical technology software company that specializes in image analysis and artificial intelligence. As the global market leader within image enhancement, ContextVision is a software partner to leading medical imaging manufacturers around the world. Its cutting-edge technology helps doctors accurately interpret medical images, a crucial foundation for better diagnosis and treatment.
As an industry pioneer for more than 30 years, ContextVision has developed state-of-the-art capabilities in the latest artificial intelligence technologies. By combining these with its well-established GOP technology, the company is introducing a new generation of image enhancement products. ContextVision is also approaching the growing digital pathology market with new AI-based decision support tools for pathologists.
The company is based in Sweden, with local representation in the U.S., Russia, Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker COV.
Attachment